Cargando…
Is it time for Africa to adopt primaquine in the era of malaria control and elimination?
Primaquine is a gametocytocidal drug known to significantly reduce malaria transmission. However, primaquine induces a dose-dependent acute hemolytic anemia (AHA) in individuals with glucose-6-phosphate dehydrogenase (G6PD) deficiency that has led to a limited use of the drug especially in Africa wh...
Autores principales: | Mwaiswelo, Richard O., Kabuga, Hamis, Kweka, Eliningaya J., Baraka, Vito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8874101/ https://www.ncbi.nlm.nih.gov/pubmed/35216617 http://dx.doi.org/10.1186/s41182-022-00408-5 |
Ejemplares similares
-
The Threat of Zika Virus in Sub-Saharan Africa – The Need to Remain Vigilant
por: Baraka, Vito, et al.
Publicado: (2016) -
A single low dose of primaquine is safe and sufficient to reduce transmission of Plasmodium falciparum gametocytes regardless of cytochrome P450 2D6 enzyme activity in Bagamoyo district, Tanzania
por: Mwaiswelo, Richard Owden, et al.
Publicado: (2022) -
Mass primaquine treatment to eliminate vivax malaria: lessons from the past
por: Kondrashin, Anatoly, et al.
Publicado: (2014) -
Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014) -
Rationale for short course primaquine in Africa to interrupt malaria transmission
por: Eziefula, Alice C, et al.
Publicado: (2012)